178 related articles for article (PubMed ID: 8360510)
1. 51Cr-labeled human hepatocytes as target cells for cytotoxicity mediated by freshly isolated liver-infiltrating lymphocytes.
Shimizu Y; Hata K; Herberman RB; Whiteside TL
J Immunol Methods; 1993 Aug; 164(1):69-77. PubMed ID: 8360510
[TBL] [Abstract][Full Text] [Related]
2. Isolation, phenotyping, and functional analysis of lymphocytes from human liver.
Hata K; Zhang XR; Iwatsuki S; Van Thiel DH; Herberman RB; Whiteside TL
Clin Immunol Immunopathol; 1990 Sep; 56(3):401-19. PubMed ID: 1697226
[TBL] [Abstract][Full Text] [Related]
3. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
4. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
Dannemann BR; Morris VA; Araujo FG; Remington JS
J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
[TBL] [Abstract][Full Text] [Related]
5. Natural killer activity of human liver-derived lymphocytes in various liver diseases.
Hata K; Van Thiel DH; Herberman RB; Whiteside TL
Hepatology; 1991 Sep; 14(3):495-503. PubMed ID: 1874494
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.
Geubel AP; Keller RH; Summerskill WH; Dickson ER; Tomasi TB; Shorter RG
Gastroenterology; 1976 Sep; 71(3):450-6. PubMed ID: 950096
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
[TBL] [Abstract][Full Text] [Related]
8. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
Wierda WG; Mehr DS; Kim YB
J Immunol Methods; 1989 Aug; 122(1):15-24. PubMed ID: 2760476
[TBL] [Abstract][Full Text] [Related]
9. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
[TBL] [Abstract][Full Text] [Related]
10. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
11. The immune reactivity role of HCV-induced liver infiltrating lymphocytes in hepatocellular damage.
Jin Y; Fuller L; Carreno M; Zucker K; Roth D; Esquenazi V; Karatzas T; Swanson SJ; Tzakis AG; Miller J
J Clin Immunol; 1997 Mar; 17(2):140-53. PubMed ID: 9083890
[TBL] [Abstract][Full Text] [Related]
12. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
Hermann GG; Zeuthen J; Claësson MH
Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
[TBL] [Abstract][Full Text] [Related]
13. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry.
Papadopoulos NG; Dedoussis GV; Spanakos G; Gritzapis AD; Baxevanis CN; Papamichail M
J Immunol Methods; 1994 Dec; 177(1-2):101-11. PubMed ID: 7822816
[TBL] [Abstract][Full Text] [Related]
14. Lysis of keratinocytes by IL-2-activated peripheral blood lymphocytes.
Symington FW; Santos EB
J Invest Dermatol; 1991 Jan; 96(1):127-33. PubMed ID: 1987288
[TBL] [Abstract][Full Text] [Related]
15. Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.
von Zons P; Crowley-Nowick P; Friberg D; Bell M; Koldovsky U; Whiteside TL
Clin Diagn Lab Immunol; 1997 Mar; 4(2):202-7. PubMed ID: 9067656
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated cytotoxicity to autologous hepatocytes in HBsAg positive liver disease: an analysis of the killing specificity and of the clinical use of the test.
Actis GC; Touscoz GA; Crivelli O; Rizzetto M; Rocca B; Poli G; Verme G
Boll Ist Sieroter Milan; 1984 Mar; 63(1):19-29. PubMed ID: 6206876
[TBL] [Abstract][Full Text] [Related]
17. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
Itoh K; Tilden AB; Balch CM
Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins.
Phillips JH; Hori T; Nagler A; Bhat N; Spits H; Lanier LL
J Exp Med; 1992 Apr; 175(4):1055-66. PubMed ID: 1372642
[TBL] [Abstract][Full Text] [Related]
20. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
